Efficacy/Safety of Imprime PGG With Cetuximab & Paclitaxel/Carboplatin Therapy in Pts With Untreated Advanced Non-Small Cell Lung Cancer

NCT00874848 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

NSCLC

Interventions

BIOLOGICAL: Imprime PGG Injection
BIOLOGICAL: Cetuximab
DRUG: Paclitaxel
DRUG: Carboplatin

Sponsor

HiberCell, Inc.